A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Clinical trial NCT07109726 · RECRUITING

Trial details

NCT number: NCT07109726
Sponsor: Terremoto Biosciences Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Cancer Endometrial Cancer Ovarian Cancer Lung Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma Solid Tumor Cervical Cancer

Start date: 2025-09-23
Primary completion: 2028-12-30
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.